BRIEF-EMA Starts Of Rolling Review For Adapted Comirnaty COVID-19 Vaccine
European Medicines Agency: * EMA: START OF ROLLING REVIEW FOR ADAPTED COMIRNATY COVID-19 VACCINE: 15/06/2022
* EMA SAYS STARTED ROLLING REVIEW FOR VERSION OF COMIRNATY ADAPTED TO PROVIDE BETTER PROTECTION AGAINST SPECIFIC VARIANT OR VARIANTS OF SARS-COV-2 * EMA: DETAILS ABOUT ADAPTED VACCINE, FOR EXAMPLE WHETHER IT WILL SPECIFICALLY TARGET ONE/MORE SARS-COV-2 VARIANTS OR SUBVARIANTS, ARE NOT YET DEFINED
* EMA SAYS EMA'S REVIEW WILL INITIALLY FOCUS ON CMC DATA FOR THE COMPONENT TARGETING OMICRON SUBVARIANTS Further company coverage:
Google News